News
Quatrefolic® Approved for use in China as a Nutrient Supplement for Pregnant and Lactating Women
10 January 2025
Quatrefolic®, the active form of folate, has received official approval from Chinese authorities for use in nutrient supplementary food for pregnant and lactating women. This approval signifies a significant milestone, as Quatrefolic® can now be formulated into products that support maternal health, adhering to GB 31601 standards.
The permitted daily dosage is up to 400 mcg of folate, aligning with the recommended dietary intake for this demographic. Additionally, Quatrefolic®’s inclusion in solid beverage formulations further expands its potential applications in the Chinese market.
Enhancing Maternal and Fetal Well-Being with Active Folate
The benefits of Quatrefolic® for pregnant and lactating women are extensive and scientifically supported. Folate is critical in fetal development, particularly in preventing neural tube defects during pregnancy. Quatrefolic®, the biologically active form of folate, bypasses the need for metabolic conversion, ensuring enhanced bioavailability and efficacy. For lactating women, adequate folate intake supports maternal health and optimizes the quality of breast milk, providing essential nutrients to the newborn. Quatrefolic®’s superior solubility and stability make it a reliable and effective choice for addressing the increased folate needs during these critical life stages.
Official Announcement Marks a Milestone for Innovation in China
For more details on the registration approval and its implications, please refer to the official announcement here. This approval highlights the commitment to maternal health and paves the way for innovative nutritional products in China.
